![Normand Balthazard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Normand Balthazard
Vorstandsvorsitzender bei Prognomix, Inc.
Aktive Positionen von Normand Balthazard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Origenix Technologies, Inc. | Corporate Officer/Principal | - | - |
Intellivax International, Inc.
![]() Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Corporate Officer/Principal | - | - |
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Normand Balthazard
Ehemalige bekannte Positionen von Normand Balthazard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAVARIA CORPORATION | Direktor/Vorstandsmitglied | 01.03.2003 | 01.03.2010 |
Contact Image Corp.
![]() Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Vorsitzender | 01.11.2004 | 23.03.2007 |
Präsident | 01.11.2004 | 23.03.2007 | |
Unternehmenssekretär | 01.11.2004 | 23.03.2007 | |
Treasurer | 01.11.2004 | 23.03.2007 | |
BioCapital Investment Advisors, Inc.
![]() BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Analyst-Equity | 17.04.2002 | 31.12.2005 |
Chief Investment Officer | 17.04.2002 | 31.12.2005 | |
Portfolio Manager-Aktien | 17.04.2002 | 31.12.2005 | |
Präsident | 17.04.2002 | 31.12.2005 | |
Biorthex, Inc.
![]() Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Corporate Officer/Principal | - | - |
CryoCath Technologies, Inc.
![]() CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Gründer | - | - |
ConjuChem, Inc.
![]() ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Corporate Officer/Principal | - | - |
Statistik
International
Kanada | 9 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 4 |
President | 2 |
Analyst-Equity | 1 |
Sektoral
Health Technology | 6 |
Finance | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SAVARIA CORPORATION | Consumer Durables |
Private Unternehmen | 8 |
---|---|
BioCapital Investment Advisors, Inc.
![]() BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Contact Image Corp.
![]() Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Commercial Services |
ConjuChem, Inc.
![]() ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
CryoCath Technologies, Inc.
![]() CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
Origenix Technologies, Inc. | |
Biorthex, Inc.
![]() Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Health Technology |
Intellivax International, Inc.
![]() Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Health Technology |
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
- Börse
- Insiders
- Normand Balthazard
- Erfahrung